Synlogic News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.02.24	Why Synlogic (SYBX) Stock Is Down Nearly 50% Today (Benzinga)
09.02.24	Rare Disease Focused-Synlogic Pulls Plug On Lead Program, Shares Nosedive (Benzinga)
27.12.23	Synlogic Secures $1 Mln Subcontract Under Air Force Research Lab (RTTNews)
28.09.23	Pre-market Movers: ASTI, SYBX, GBNY, GNSS, BIVI… (RTTNews)
19.01.23	Synlogic's SYNB1934 Gets FDA Rare Pediatric Disease Designation For Phenylketonuria (RTTNews)
23.08.22	Synlogic Announces FDA's Fast Track Designation For SYNB1353 (RTTNews)
11.08.22	Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks (PR Newswire)
10.08.22	Ausblick: Synlogic stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
24.11.21	Pre-market Movers: OCUP, KTTA, GAME, BIOL, JWN… (RTTNews)
09.11.21	Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria (PR Newswire)
20.09.21	Synlogic Reports Positive Data From Phase 2 Trial Evaluating SYNB1618 - Quick Facts (RTTNews)
12.08.21	Synlogic Reports Second Quarter Financial Results and Provides Business Update (PR Newswire)
05.08.21	Synlogic Announces Second Quarter 2021 Conference Call & Participation in Upcoming Banking Conference (PR Newswire)
22.07.21	Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU) (PR Newswire)
15.07.21	Synlogic Announces Initiation of Phase 1 Study of SYNB1934, a Next-Generation Strain for the Treatment of Phenylketonuria (PKU) (PR Newswire)
17.06.21	Synlogic Partners Roche To Develop Synthetic Biotic Medicine For Inflammatory Bowel Disease (RTTNews)
17.06.21	Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease (PR Newswire)
15.06.21	Synlogic Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Des... (PR Newswire)
11.05.21	Ausblick: Synlogic präsentiert Quartalsergebnisse (finanzen.net)
23.03.21	Ausblick: Synlogic gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
14.01.21	Pre-market Movers In Healthcare Sector: ORGO, NK, APYX, BIOL, ATHE, ACER… (RTTNews)
14.01.21	ACOR Rises On Restructuring, ALXN Pauses COVID-19 Trial, SYBX On Watch (RTTNews)
30.11.20	Pre-market Movers In Healthcare Sector: ORMP, VSTM, MRNA, COCP, SYBX... (RTTNews)
27.11.20	Pre-market Movers In Healthcare Sector: WORX, GNFT, YMAB, VSTM, TYME… (RTTNews)
05.08.20	Ausblick: Synlogic stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
07.05.20	Ausblick: Synlogic gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
11.03.20	Ausblick: Synlogic gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
09.01.20	Synlogic Outlines Upcoming Milestones for Clinical Programs and Unveils New Preclinical Pipeline Programs (Businesswire)
25.11.19	Synlogic to Webcast Presentation at the Piper Jaffray 31st Annual Healthcare Conference (Businesswire)
12.11.19	Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results (Businesswire)
05.11.19	Synlogic Announces Third Quarter 2019 Conference Call and Webcast (Businesswire)
04.09.19	Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure (Businesswire)
04.09.19	Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM) (Businesswire)
21.08.19	5 Top Losers In Healthcare Sector (SYBX, PSTV, TRIB…) (RTTNews)
20.08.19	Synlogic Discontinues SYNB1020 Development For Treating Hyperammonemia (RTTNews)
20.08.19	Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia (Businesswire)
08.08.19	Synlogic to Present at the 2019 Wedbush PacGrow Healthcare Conference (Businesswire)
08.08.19	Synlogic Reports Second Quarter 2019 Financial Results and Provides Program Updates (Businesswire)
06.08.19	Ausblick: Synlogic gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
01.08.19	Synlogic Announces Second Quarter 2019 Conference Call and Webcast (Businesswire)
15.07.19	Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development (Businesswire)
18.06.19	5 Top Gainers In Healthcare Sector (ARRY, SYBX, CRTX...) (RTTNews)
13.06.19	5 Top Gainers In Healthcare Sector (SYBX, HEB, TOCA...) (RTTNews)
12.06.19	Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines (Businesswire)
22.05.19	Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors (Businesswire)
09.05.19	Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update (Businesswire)
07.05.19	Ausblick: Synlogic stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
02.05.19	Synlogic Announces First Quarter 2019 Conference Call and Webcast (Businesswire)
01.05.19	6 Top Gainers In Pharma Sector (PRPO, ATEC, SYBX...) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Synlogic Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten